Last reviewed · How we verify
THC-free CBD Oil
THC-free CBD Oil is a Small molecule drug developed by Eastern Virginia Medical School. It is currently in Phase 2 development.
At a glance
| Generic name | THC-free CBD Oil |
|---|---|
| Sponsor | Eastern Virginia Medical School |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism (PHASE2)
- Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease (PHASE2)
- A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- THC-free CBD Oil CI brief — competitive landscape report
- THC-free CBD Oil updates RSS · CI watch RSS
- Eastern Virginia Medical School portfolio CI
Frequently asked questions about THC-free CBD Oil
What is THC-free CBD Oil?
THC-free CBD Oil is a Small molecule drug developed by Eastern Virginia Medical School.
Who makes THC-free CBD Oil?
THC-free CBD Oil is developed by Eastern Virginia Medical School (see full Eastern Virginia Medical School pipeline at /company/eastern-virginia-medical-school).
What development phase is THC-free CBD Oil in?
THC-free CBD Oil is in Phase 2.
Related
- Manufacturer: Eastern Virginia Medical School — full pipeline
- Compare: THC-free CBD Oil vs similar drugs
- Pricing: THC-free CBD Oil cost, discount & access